This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing DBV Technologies’ Phase 3 VITESSE Results for the VIASKIN® Peanut Patch in Children Aged 4–7

Ticker(s): DBVT

Who's the expert?

Institution: University of Tennessee

  • Associate Professor and Director of Allergy & Immunology training at the University of Tennessee.
  • Manages 50+ patients with food allergies and 3 patients with Hereditary angioedema.
  • Research focuses on food allergies, anaphylaxis, primary immune deficiencies and drug allergies

Interview Goal
To gain a deeper understanding of DBV Technologies’ VIASKIN® Peanut Patch as a potential treatment for peanut allergies in children aged 4–7 years

Are You Interested In These Questions?

Slingshot Insights Explained
9Hours Left to Join Project
Call Date
Jan 09, 2026
Call Time
09:00 AM EST
Wall Street Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.